Artificial Intelligence in Genomics Market - By Component (Software), Technology (Machine Learning), Functionality (Genome Sequencing), Application (Drug Discovery & Development), End-user (Pharma & Biotech Companies), Global Forecast, 2023 – 2032

Artificial intelligence in genomics industry size reached USD 484.1 million in 2022 and is estimated to record USD 12.5 billion by 2032 attributed to the growing adoption of AI in precision medicine.

Some of the major AI in genomics industry players include DEEP GENOMICS, Data4Cure, Inc., Freenome Holdings, Inc., Illumina, Inc., SOPHiA GENETICS, and Benevolent, and others.

North America held 51.9% of the global AI in genomics market share in 2022 and is anticipated to grow at a robust CAGR through 2032 driven by the increasing investments for the advancement of AI-powered solutions for genomics by various research institutions.

The software component segment accounted for 53.4% market share in 2022 and is poised to expand considerably through 2032 owing to the high demand for advanced analytics and ML capabilities in genomics research and clinical settings.